ÇѸ²´ëÇб³¼º½Éº´¿ø

À̼ҿµ ±³¼ö

  • Áø·á°ú ¼Ò¾Æû¼Ò³â°ú

Àü¹®Áø·áºÐ¾ß

¼Ò¾Æ±â Ư¹ß¼º °üÀý¿°, Àü½Å¼º È«¹Ý¼º ·çǪ½º, Ç÷°ü¿°, º£Ã¼Æ®º´, ¼î±×·»º´, Å©¸®¿ÀÇǸ° °ü·Ã ¹ß¿­ ÁõÈıº, ÀÏÂ÷¼º ¸é¿ª°áÇÌÁúȯ, ±âŸ ÀÚ°¡¸é¿ª/¿°Áõ Áúȯ

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-10-14 ~ 2024-10-19)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2008.09 ~ 2010.08¼­¿ï´ëÇб³ ¸é¿ªÇÐ ¼®»ç

2011.04 ~ 2014.03¿À»çÄ«´ëÇб³ »ý¸í±â´ÉÇÐ ¹Ú»ç

1996.03 ~ 2002.02ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷

°æ·Â

°æ·Â

2023.02 ~ ÇѸ²´ëÇб³¼º½Éº´¿ø ¼Ò¾Æû¼Ò³â°ú ÀÓ»óºÎ±³¼ö

2021.03 ~ 2023.01¢ßÁö³ðÀλçÀÌÆ® Èñ±ÍÁúȯÀÇ ÀüÀåÀ¯Àüü ºÐ¼® ÆÀÀå

2017.03 ~ 2021.02¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ¸é¿ªºÐ°ú Áø·á±³¼ö

2016.03 ~ 2016.11ÀÌÈ­¿©´ë ÀÇ°ú´ëÇÐ ¹Ú»çÈÄ ¿¬±¸ ±³¼ö

2015.03 ~ 2016.02ÀÌÈ­¿©´ë¸ñµ¿º´¿ø ¼Ò¾Æû¼Ò³â°ú ¼Ò¾Æ°¨¿° ÀüÀÓÀÇ

2014.04 ~ 2015.01Post-doctroal fellowship Immunology Frontier Research Center, Osaka University

2011.04 ~ 2014.03Specially appointed researcher, Immunology Frontier Research Center, Osaka University

2010.06 ~ 2011.04Fellowship of Takeda Science Foundation, Osaka, Japan

2008.03 ~ 2010.06¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ¸é¿ªºÐ°ú ÀÓ»ó°­»ç

2004.03 ~ 2008.02¼­¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú Àü°øÀÇ

2002.03 ~ 2003.02¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

2019.09 ~ ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ ÁØȸ¿ø

2019.11 ~ Clinical Immunology Society

2018.05 ~ Europena society for Immunodeficiencies

2017.04 ~ 2018.08´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Ãѹ«ÀÌ»ç

2015.03 ~ ´ëÇѼҾư¨¿°ÇÐȸ Á¤È¸¿ø

2008.03 ~ ´ëÇѸ鿪ÇÐȸ ȸ¿ø

2008.03 ~ ´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Á¤È¸¿ø

2008.02 ~ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Æò»ýȸ¿ø

2007.07 ~ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Á¤È¸¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

2020The Osaka Medical Research Foundation for Intractable Disease ¿¬±¸»ó

2020GSK ¿ì¼ö ÃÊ·Ï»ó

2015MSD Çмú»ó

2014GSK ¿ì¼ö ÃÊ·Ï»ó

2009GSK ¿ì¼ö ÃÊ·Ï»ó

2003¼­¿ï´ëº´¿ø ¿ì¼öÀÎÅÏ»ó

°Ç°­¸Å°ÅÁø